2011•Sichuan Medical JournalRequires access

Clinical value of determination of β2-MG and CRP levels in patients with multiple myeloma

Jia Li

Open publisher page 0 citations

Abstract

Objective To study the clinical significance of determination of plasma levels ofβ2-MG and CRP in patients with multiple myeloma(MM).Methods Plasma levels of TNF-α and β2-m were determined in 42 patients with multiple myeloma before and after chemotherapy,and it also been determined in 50 healthy controls.Results The plasma levels of β2-MG and CRP in patients with multiple myeloma were significantly higher than those controls(P 0.01).The plasma levels of β2-MG and CRP were decreases after the chemotherapy.And there had a long surval time in patients with a lower plasma levels of β2-MG and CRP than those with a higher level.Conclusion The determination of plasma levels ofβ2-MG and CRP might be helpful for diagnosis,curative effect monitoring and prognosis in patients with multiple myeloma.

About this research paper

What this paper is about

Objective To study the clinical significance of determination of plasma levels ofβ2-MG and CRP in patients with multiple myeloma(MM).Methods Plasma levels of TNF-α and β2-m were determined in 42 patients with multiple myeloma before and after chemotherapy,and it also been determined in 50 healthy controls.Results The plasma levels of β2-MG and CRP in patients with multiple myeloma were significantly higher than those controls(P 0.01).The plasma levels of β2-MG and CRP were decreases after the chemotherapy.And there had a long surval time in patients with a lower plasma levels of β2-MG and CRP than those with a higher level.Conclusion The determination of plasma levels ofβ2-MG and CRP might be helpful for diagnosis,curative effect monitoring and prognosis in patients with multiple myeloma.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the clinical significance of determination of plasma levels ofβ2-MG and CRP in patients with multiple myeloma(MM).Methods Plasma levels of TNF-α and β2-m were determined in 42 patients with multiple myeloma before and after chemotherapy,and it also been determined in 50 healthy controls.Results The plasma levels of β2-MG and CRP in patients with multiple myeloma were significantly higher than those controls(P 0.01).The plasma levels of β2-MG and CRP were decreases after the chemotherapy.And there had a long surval time in patients with a lower plasma levels of β2-MG and CRP than those with a higher level.Conclusion The determination of plasma levels ofβ2-MG and CRP might be helpful for diagnosis,curative effect monitoring and prognosis in patients with multiple myeloma.

Key concepts: Medicine, Multiple myeloma, Internal medicine, Gastroenterology, Chemotherapy, Plasma levels

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical value of determination of β2-MG and CRP levels in patients with multiple myeloma — Research Paper | ScholarLens